As of April 16, 2025, Ginkgo Bioworks (DNA) has a market cap of $0.48 billion USD. According to our data, Ginkgo Bioworks is ranked No.6025 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 16, 2025 | $0.48 B |
7.87%
|
Dec 31, 2024 | $0.44 B |
-85.47%
|
Dec 29, 2023 | $3.06 B |
0.00%
|
Dec 30, 2022 | $3.06 B |
-79.66%
|
Dec 31, 2021 | $15.02 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Codexis
CDXS
|
$0.19 B |
0.000 M
|
![]() USA
|
![]() Twist Bioscience
TWST
|
$2.36 B |
-0.000 M
|
![]() USA
|
![]() Moderna
MRNA
|
$10.14 B |
-0.001 M
|
![]() USA
|
![]() CRISPR Therapeutics
CRSP
|
$3.34 B |
0.000 M
|
![]() Switzerland
|
![]() Editas Medicine
EDIT
|
$0.11 B |
0.000 M
|
![]() USA
|
![]() Beam Therapeutics
BEAM
|
$1.73 B |
0.000 M
|
![]() USA
|
![]() Sangamo Therapeutics
SGMO
|
$0.17 B |
0.000 M
|
![]() USA
|
![]() bluebird bio
BLUE
|
$43.76 M |
0.000 M
|
![]() USA
|
![]() Cellectis
CLLS
|
$0.18 B |
36.593 M
|
![]() France
|
![]() Repligen
RGEN
|
$7.11 B |
-0.000 M
|
![]() USA
|
Market Cap | = | DNA Stock Price | * | DNA Shares Outstanding |
= | $8.25 | * | 45.81 M | |
= | $0.48 B |